mk 0663 has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, R | 1 |
1 other study(ies) available for mk 0663 and Cytokine Release Syndrome
| Article | Year |
|---|---|
Etoricoxib may inhibit cytokine storm to treat COVID-19.
Topics: COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Etoricoxib; Humans | 2021 |